ARMO Bio Sciences
A biotechnology company that develops immune modulatory biologic therapeutics.
Launch date
Employees
Market cap
-
Enterprise valuation
€1.5b (Public information from May 2018)
Palo Alto California (HQ)
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
$30.0m | Series B | ||
$50.0m | Series C | ||
$67.0m | Series C | ||
N/A | $128m Valuation: $497m | IPO | |
$1.6b Valuation: $1.6b | Acquisition | ||
Total Funding | €152m |
Related Content
Recent News about ARMO Bio Sciences
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.